1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Pearson correlation coefficients for the association of MD with perfusion measures within each area of the corpus callosum of patients with RRMS and control subjects
Location CBV CBF MTT r P r P r P RRMS (n = 14) Genu 0.25 .87 0.23 .89 0.08 .73 Body 0.63 .046 0.86 <.0001 −0.39 .08 Splenium 0.65 <.0001 0.83 <.0001 −0.33 .08 Control (n = 17) Genu −0.09 .74 0.04 .64 −0.15 .33 Body −0.01 .72 0.17 .81 −0.21 .61 Splenium −0.03 .54 −0.004 .82 −0.11 .73
Note:—MD, mean diffusivity; RRMS, relapsing-remitting multiple sclerosis; CBF, cerebral blood flow; CBV, cerebral blood volume; MTT, mean transit time. Statistical significance accepted at P < .05.